ArticleTranslational cancer research2026
Development and validation of a model for predicting central lymph node metastasis in colorectal cancer based on CT textural features and clinical indicators.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Central lymph node metastasis (CLNM) in colorectal cancer (CRC) is an important factor affecting patient prognosis and the assessment of surgical extent. However, conventional imaging remains limited in the preoperative assessment of LNM. This study aimed to investigate the value of a combined model based on computed tomography (CT) texture features and clinical indicators for the preoperative identification of CLNM in patients with CRC. Methods: In this retrospective study, 1,187 patients who underwent laparoscopic radical resection for CRC at two hospitals were screened, and 228 were ultimately included. Based on postoperative pathology, patients were divided into the CLNM-positive group (n=76) and the CLNM-negative group (n=152). Patients from one hospital were randomly assigned to a training set (n=126) and a test set (n=54) in a 7:3 ratio, while patients from the other hospital were used for the external validation set (n=48). Radiomic features extracted using MaZda software were used to construct the radiomics model, while preoperative clinical indicators were used to construct the clinical model. Subsequently, radiomic features and clinical indicators were incorporated to construct five combined predictive models, including logistic regression (LR), support vector machine (SVM), neural network (NN), random forest (RF), and gradient boosting machine (GBM). Their performance was compared using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). Results: Significant differences in T stage, N stage, preoperative serum carcinoembryonic antigen (CEA), and neutrophil-to-lymphocyte ratio (NLR) were observed between the CLNM-positive and CLNM-negative groups (all P<0.05). S(1,0)DifEntrp and S(0,1)SumEntrp were selected for the radiomics model, while CEA and NLR were selected for the clinical model. The combined model incorporated all four predictors and performed better than the clinical and radiomics models in both the test and external validation sets. It achieved areas under the curve (AUCs) of 0.816 and 0.775, respectively. Among the five models, GBM, RF, and NN showed larger AUC differences between the test set and the external validation set, with differences of 0.349, 0.208, and 0.096. In contrast, the differences were smaller for LR and SVM, at 0.041 and 0.003, respectively. Based on the ROC curves, calibration curves, and DCA, the LR model showed better overall predictive performance and stability in this study. Conclusions: The combined predictive model based on CT texture features and clinical indicators showed potential value for the preoperative identification of CLNM in CRC. It may provide an additional reference for the preoperative assessment of CLNM in patients with CRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.